What Researchers Did
The researchers looked back at the records of patients who had bleeding in the urine after pelvic radiation and were treated with hyperbaric oxygen therapy (HBOT).
What They Found
In this retrospective study of 67 patients with hematuria from hemorrhagic radiation cystitis, 51 patients (76.1%) responded to HBOT, with total remission in 50.7% and partial remission in 25.4%. Partial remission meant hematuria of grade 2 or less on the RTOG scale. The mean age was 68.6 years, and prostate cancer was the reason for radiation in 64.2% of cases. Patients with hematuria below grade 3, patients who received more than 30 sessions, and patients who needed no transfusion or hospital admission had better responses (p less than 0.05). No treatment-related adverse effects were reported, and one patient was excluded because of claustrophobia.
What This Means for Canadian Patients
For people with bleeding from radiation cystitis, this study reports that about three in four patients treated with HBOT had a full or partial response. The authors concluded that HBOT is effective and safe for this problem, but this was a review of past records with no comparison group, so it cannot show that HBOT caused the improvement. Patients with milder bleeding and those who completed more sessions responded better, which is a pattern worth discussing with a physician.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The study was retrospective, the abstract describes no control group, and the sessions-and-response finding may reflect which patients were able to finish more sessions rather than the effect of the treatment itself.